<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref159">
 <mixed-citation publication-type="journal" id="cit159">
  <name>
   <surname>Tadros</surname>
   <given-names>A. R.</given-names>
  </name>; 
  <name>
   <surname>Romanyuk</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Miller</surname>
   <given-names>I. C.</given-names>
  </name>; 
  <name>
   <surname>Santiago</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Noel</surname>
   <given-names>R. K.</given-names>
  </name>; 
  <name>
   <surname>O’Farrell</surname>
   <given-names>L.</given-names>
  </name>; 
  <name>
   <surname>Kwong</surname>
   <given-names>G. A.</given-names>
  </name>; 
  <name>
   <surname>Prausnitz</surname>
   <given-names>M. R.</given-names>
  </name>
  <article-title>STAR Particles for Enhanced Topical Drug and Vaccine Delivery</article-title>. 
  <source>Nat. Med.</source>
  <year>2020</year>, 
  <volume>26</volume>, 
  <fpage>341</fpage>–
  <lpage>347</lpage>. 
  <pub-id pub-id-type="doi">10.1038/s41591-020-0787-6</pub-id>.
  <pub-id pub-id-type="pmid">32152581</pub-id>
 </mixed-citation>
</ref>
